St. Jude Medical Inc. (“St. Jude”), which was acquired by Abbott Laboratories in 2017, entered into a settlement last week with the United States Department of Justice (“DOJ”) for $27 million to resolve allegations it had...more
7/16/2021
/ Department of Justice (DOJ) ,
False Claims Act (FCA) ,
Food and Drug Administration (FDA) ,
Fraud ,
Manufacturers ,
Manufacturing Defects ,
Medicaid ,
Medical Devices ,
Medicare ,
Settlement ,
TRICARE ,
Whistleblowers